Fundraising Fox
🦊/People
Sign in

Diya Malhotra

Investor

Principal at Abingworth

London

Writes $15M – $30M checks · typically $22.5M

Find your path to Diya

424 people in our graph share verified history with Diya — schools, employers, funds. One of them is your warm intro.

Deji SasegbonunlockedDiya: together at Imperial College London (2013–2014)
×6Diya: together at University College London
×5Diya: together at Imperial College London

About

Diya Malhotra joined Abingworth in June 2021, having previously worked as a Consultant in L.E.K. Consulting's Life Sciences practice, where she advised pharmaceutical, biotech, and buyside clients on corporate strategy and clinical and commercial opportunity assessments. At Abingworth she works with the transatlantic investment team, particularly the Clinical Co-Development team, evaluating new opportunities and supporting existing investments. She holds a PhD in Clinical Neuropharmacology from Imperial College London and a degree in Pharmacology from University College London.

Invests in

Biotech

Experience

  1. AbingworthPrincipalcurrent2023 — presentGreater London, England, United Kingdom
  2. AbingworthInvestment Manager2021 — 2023Greater London, England, United Kingdom
  3. L.E.K. ConsultingLife Sciences Consultant2017 — 2021

Skills & more

R&D1Stem Cells1In Vivo1In Vitro1Pharmacology2NeuroscienceResearch3Drug DiscoveryTraumatic Brain InjuryCell Culture1miRNAPatents
+12 moreIntellectual PropertyNeuropharmacologyProject ManagementAnaestheticsPublic EngagementData HandlingOrganotypic Hippocampal Slice CultureRT-PCRMentoringFluorescence MicroscopyFluorescence SpectroscopyMicrosoft Office

From Diya's professional profile.

Colleagues at Abingworth

Alex Asquith
Counsel at Abingworth
Amit Khasgiwala
Investment Professional at Innovatus Capital Partners
Andrew Sinclair
Managing Director, Head of Publics & Late Stage at Abingworth
Ankur Shah
Vice President, CCD at Abingworth
Anna Slezak
Senior Associate at Abingworth
Bali Muralidhar
Global Head of Life Sciences & CIO at Abingworth
Carlos Paya
Venture Partner at Ysios Capital
David Leathers
General Partner at Abingworth

Network4

Andrew Sinclair
Managing Director, Head of Publics & Late Stage at Abingworth
Bali Muralidhar
Global Head of Life Sciences & CIO at Abingworth
Genghis Lloyd-Harris
Senior Advisor at Abingworth
Jacqueline Grant
Principal at Abingworth

Investors connected to Diya in public investor directories — a warm-intro map.

Frequently asked questions

Who is Diya Malhotra?
Diya Malhotra joined Abingworth in June 2021, having previously worked as a Consultant in L.E.K. Consulting's Life Sciences practice, where she advised pharmaceutical, biotech, and buyside clients on corporate strategy and clinical and commercial opportunity assessments. At Abingworth she works with the transatlantic investment team, particularly the Clinical Co-Development team, evaluating new opportunities and supporting existing investments. She holds a PhD in Clinical Neuropharmacology from Imperial College London and a degree in Pharmacology from University College London.
Where does Diya Malhotra work?
Diya Malhotra is Principal at Abingworth.
What does Diya Malhotra invest in?
Diya Malhotra invests in Biotech.
What check size does Diya Malhotra write?
Diya Malhotra typically writes checks of $15M – $30M.
Where did Diya Malhotra go to school?
Diya Malhotra studied at Imperial College London (Doctor of Philosophy (PhD), Neuroscience); University College London (BSc Pharmacology, Neuropharmacology); Overseas Family School Singapore (International Baccalaureate Diploma).

Same school

Shared employers